ELAN (STOCKS)
Elanco Animal Health Incorporated Common Stock
$24.410000
+1.280000 (+5.53%)
Prev close: $23.130000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jeffrey N. Simmons
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $11,854.97M
- Employees
- 9,450
- P/E (TTM)
- -51.16
- P/B (TTM)
- 1.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
12
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.13 | $0.11 | +0.0170 | +15.04% |
|
Sep 2025 (Q3)
|
$0.19 | $0.13 | +0.0571 | +42.96% |
|
Jun 2025 (Q2)
|
$0.26 | $0.20 | +0.0607 | +30.46% |
|
Mar 2025 (Q1)
|
$0.37 | $0.32 | +0.0538 | +17.01% |
Financial Statements
| Revenues | $4.72B |
| Benefits Costs and Expenses | $4.94B |
| Cost Of Revenue | $2.12B |
| Costs And Expenses | $4.94B |
| Gross Profit | $2.59B |
| Operating Expenses | $2.82B |
| Selling, General, and Administrative Expenses | $1.43B |
| Research and Development | $368.00M |
| Other Operating Expenses | $1.02B |
| Operating Income/Loss | -$224.00M |
| Income/Loss From Continuing Operations After Tax | -$232.00M |
| Income/Loss From Continuing Operations Before Tax | -$224.00M |
| Income Tax Expense/Benefit | $8.00M |
| Income Tax Expense/Benefit, Current | $142.00M |
| Income Tax Expense/Benefit, Deferred | -$134.00M |
| Net Income/Loss | -$232.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$232.00M |
| Net Income/Loss Available To Common Stockholders, Basic | -$232.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.47 |
| Diluted Earnings Per Share | -$0.47 |
| Basic Average Shares | 496,400,000 |
| Diluted Average Shares | 496,400,000 |
| Assets | $13.36B |
| Current Assets | $3.46B |
| Inventory | $1.74B |
| Other Current Assets | $1.72B |
| Noncurrent Assets | $9.90B |
| Intangible Assets | $3.41B |
| Other Non-current Assets | $6.49B |
| Liabilities | $6.81B |
| Current Liabilities | $1.60B |
| Accounts Payable | $368.00M |
| Wages | $206.00M |
| Other Current Liabilities | $1.02B |
| Noncurrent Liabilities | $5.21B |
| Long-term Debt | $3.76B |
| Other Non-current Liabilities | $1.45B |
| Equity | $6.55B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.55B |
| Liabilities And Equity | $13.36B |
| Net Cash Flow From Operating Activities | $560.00M |
| Net Cash Flow From Operating Activities, Continuing | $560.00M |
| Net Cash Flow From Investing Activities | -$279.00M |
| Net Cash Flow From Investing Activities, Continuing | -$279.00M |
| Net Cash Flow From Financing Activities | -$275.00M |
| Net Cash Flow From Financing Activities, Continuing | -$275.00M |
| Exchange Gains/Losses | $71.00M |
| Net Cash Flow | $77.00M |
| Net Cash Flow, Continuing | $6.00M |
| Comprehensive Income/Loss | $398.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $398.00M |
| Other Comprehensive Income/Loss | $398.00M |
| Other Comprehensive Income/Loss Attributable To Parent | $630.00M |